Related Experiment Video
Updated: Apr 9, 2026

Author Spotlight: Investigating Hepatic Adaptations and Prediabetic Progression in Liver Diseases
Published on: October 6, 2023
Insulin resistance and prediabetes in hepatitis C virus patients
Dalia E Desouky1, Zaynab Kasemy, Alaa E Abdel-Hamid
1Department of Public Health and Community Medicine (DED), College of Medicine and Applied Medical Sciences, Taif University, Taif, Saudi Arabia; Department of Public Health and Community Medicine (DED, ZK), Faculty of Medicine, Menoufia University, Shibin Al Kawm, Egypt; Department of Internal Medicine (AEA-H), College of Medicine, Menoufia University, Shibin Al Kawm, Egypt; Division of Biochemistry (MSO), Pharmacology and Toxicology Department, College of Pharmacy, Taif University, Taif, Saudi Arabia; and Department of Chemistry (MSO), Faculty of Science, Benha University, Benha, Egypt.
Background:
Egypt has the highest prevalence of hepatitis C virus (HCV) infection in the world and is facing an epidemic of type 2 diabetes mellitus. The objective of this study was to assess the prevalence of insulin resistance (IR) and prediabetes among HCV patients.
Methods:
A cross-sectional case-control study was performed on 188 HCV patients admitted to the Internal Medicine Department in Menoufia University Hospital during the period from May to August 2014. Seventy persons were taken as controls. Body mass index (BMI), serum fasting glucose and fasting insulin were determined. IR was calculated by the Homeostasis Model for Assessment of Insulin Resistance (HOMA-IR), where a value of >2.0 was considered as IR and that >4.0 was considered as prediabetic state.
Results:
Prediabetes was significantly higher among HCV group compared with the control group. Serum fasting glucose, fasting insulin and HOMA-IR levels were significantly higher among prediabetic HCV group compared with both non-prediabetic HCV and control groups.
Conclusions:
HCV patients should be assessed for IR and prediabetes in their routine evaluation to avoid the double burden of diabetes mellitus and HCV.
Related Concept Videos
Hepatitis
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Diabetes Mellitus: Type 2 and Gestational
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Dipeptidyl Peptidase 4 Inhibitors

